National HealthCare Corporation
Price Action
Technical Summary
STAGE 2 UPTRENDNational HealthCare Corporation is in a confirmed Stage 2 uptrend, with price holding above all major moving averages and trend structure remaining intact. Relative strength is leading (RS Rating: 87), indicating clear outperformance against the broad market. Earnings growth of 10% provides fundamental context to the price action. Momentum will need to be maintained above the 50-day moving average to sustain this leadership phase.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $191.22 | +5.32% | ABOVE |
| 50 SMA | $183.12 | +9.98% | ABOVE |
| 100 SMA | $171.97 | +17.11% | ABOVE |
| 150 SMA | $159.93 | +25.93% | ABOVE |
| 200 SMA | $150.18 | +34.10% | ABOVE |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is NHC in an uptrend right now?
NHC has a trend score of 4/4 based on Minervini's Stage Analysis. Yes, NHC is in a Stage 2 uptrend with price above all major moving averages (50, 100, 150, 200 SMA) properly stacked.
Is NHC overbought or oversold?
NHC's RSI (14) is 63. The stock is in neutral territory, neither overbought nor oversold.
Is NHC outperforming the market?
NHC has a Relative Strength (RS) Rating of 87 out of 99. Yes, NHC is a market leader, outperforming 87% of all stocks over the past 12 months.
Where is NHC in its 52-week range?
NHC is trading at $201.40, which is 98% of its 52-week high ($205.06) and 97% above its 52-week low ($93.54).
How volatile is NHC?
NHC has a Beta of 0.55 and 52-week volatility of 33%. It's less volatile than the S&P 500 - generally more stable.